Literature DB >> 24979831

Treatment of familial Mediterranean fever: colchicine and beyond.

Ahmet Gül.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24979831

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  7 in total

Review 1.  New clinical trials in acute and recurrent pericarditis.

Authors:  Massimo Imazio
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 2.  Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.

Authors:  Sanem Eren Akarcan; Seyda Dogantan; Neslihan Edeer Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Rheumatol Int       Date:  2019-07-04       Impact factor: 2.631

3.  Familial Mediterranean Fever without Fever.

Authors:  Yuma Hotta; Tatsuya Kawasaki; Tomoya Kotani; Hiroshi Okada; Kanami Ikeda; Satoki Yamane; Nobuhisa Yamada; Satoru Sekoguchi; Yutaka Isozaki; Yasuyuki Nagao; Masahiro Murotani; Hirokazu Oyamada
Journal:  Intern Med       Date:  2020-02-12       Impact factor: 1.271

4.  Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey.

Authors:  Gülsah Kavrul Kayaalp; Betül Sozeri; Hafize Emine Sönmez; Ferhat Demir; Mustafa Cakan; Kübra Oztürk; Serife Gül Karadag; Gülcin Otar Yener; Semanur Ozdel; Esra Baglan; Elif Celikel; Nihal Sahin; Deniz Gezgin Yildirim; Rukiye Eker Omeroglu; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2021-01-16       Impact factor: 2.631

5.  Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens.

Authors:  Eleni Karatza; George Ismailos; Vangelis Karalis
Journal:  Xenobiotica       Date:  2021-04-12       Impact factor: 1.908

6.  Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?

Authors:  Ahmet Omma; Berkan Armaǧan; Serdar Can Güven; Sevinç Can Sandıkçı; Seda Çolak; Çiǧdem Yücel; Orhan Küçükşahin; Abdulsamet Erden
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

Review 7.  Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Authors:  Caroline Vinit; Sophie Georgin-Lavialle; Aikaterini Theodoropoulou; Catherine Barbier; Alexandre Belot; Manel Mejbri; Pascal Pillet; Jana Pachlopnik; Sylvaine Poignant; Charlotte Rebelle; Andreas Woerner; Isabelle Koné-Paut; Véronique Hentgen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.